RHBDD1 and Alzheimer disease: Furthermore, in the AD mouse models, the Wnt/β‐catenin pathway is differentially activated in RHBDL4‐deficient tissue, suggesting that RHBDL4 may act as a negative regulator of β‐catenin (Penalva et al. 2025).